Search Products
Hot Products
AmniSure
  • ROM Test
  • AmniSure® is a rapid, non-invasive test that aids in the detection of ROM in pregnant women with signs and symptoms suggestive of the condition. It provides an easy-to-interpret, accurate, and timely diagnosis that enables clinicians to take opportune measures to prevent complications.

    The AmniSure® test does not require a speculum examination. The sample is taken by sterile swab, which is inserted only 2-3 inches deep (5-7 cm) into the vagina. A clear “Yes/No” result can be read in minutes.

    - The first FDA cleared test for the diagnosis of Rupture of Membrane (ROM)
    - Quick and easy rapid test that detects Placental Alpha Microglobulin-1 (PAMG-1) protein
    - Placental alpha microglobulin-1 (PAMG-1) is present in the blood, amniotic fluid and cervico-vaginal discharge of pregnant women
    - The concentration is several thousand magnitudes higher than that which is found in vaginal discharge in pregnant women when the fetal membrane is intact

PartoSure
  • Portosure
  • We are pleased to announce the United Stated Food and Drug Administration (FDA) regulatory approval of the PartoSure test for assessing the risk of spontaneous preterm birth in patients with symptoms of preterm labor, which follows the successful uptake of PartoSure in over 38 countries across Europe, the Middle East, Asia, and Latin America. The U.S. commercialization of the PartoSure test is planned to begin in early 2018.

    The PartoSure™ TTD Test is a rapid bedside test that aids in the prediction of time to delivery. The test is indicated for patients presenting at 20 to 36⁶⁄₇ weeks gestational age with:

    - Signs and symptoms of early preterm labour
    - Intact amniotic membranes
    - Minimal cervical dilatation (≤ 3 cm)
    - Between 20 weeks, 0 days and 36 weeks, 6 days gestation

    The PartoSure™ TTD Test detects placental alpha- microglobulin-1 (PAMG-1), a protein found in very high concentrations in amniotic fluid and in very low concentrations in normal vaginal discharge. Recent clinical studies have demonstrated a strong correlation between a positive PAMG-1 test and imminent delivery in those patients presenting with threatened preterm labour and clinically intact membranes.

Pessaries
Dr.Arabin GmbH & Co.
Contam®

Manufactured in Germany, assists ladies who suffer from Stress Incontinence due to various factors.

Contam

Contam, a tampon that can be used for the natural self-treatment of incontinence and prolapses to maintain or restore your quality of life. It does not affect vaginal secretions or the natural vaginal flora. The raw material used in Contam® is a toxicologically and dermatologically harmless foam.

Knowing that many ladies, specially the younger generation who have had multiple or in some cases even single pregnancy, suffer from urinary incontinence during sport, we would like to introduce CONTAM which would aid in having a more pleasant exercise session without having to worry about leakage or unpleasant odor. CONTAM in addition to the pelvic floor exercises will in long term give ladies more confidence.


EPISCISSORS-60™

EPISCISSORS-60™ have a unique patented form and design. They have a guide-limb that points towards the anus and is in the vertical plane. The scissors blades constantly maintain a 60 degree angle from the guide-limb. The flexible nature of the guide accommodates the spherical distention at crowning.

Eyeballing a sphere

What is the evidence for EPISCISSORS-60™?

Four clinical studies have been done using the EPISCISSORS-60 showing episiotomy suture angles between 40-52 degrees [6-8]. The suture angle will depend on how distended the perineum is when the episiotomy is given. The more distended the perineum, the lesser the post-delivery angle.

A 2-centre UK study has shown a 20% reduction in OASIS due to adoption of the EPISCISSORS-60™ [van Roon 2015].

 
ProviaTest - Expanded Newborn Screening
Why choose ProviaTest?

ProviaTest® is an expanded, highly accurate newborn screening test, that detects an unprecedented number of clinically relevant metabolic and hormonal diseases, genetic syndromes and conditions.

Eluthia offers three different panels: One for metabolic and hormonal screening (MHD panel), one that covers the frequent and largely underdiagnosed sex chromosome aneuploidies (SCA panel) and another one that covers the 30 most frequent microdeletions (MD panel), which cannot be detected by karyotyping.

ProviaTest® has been developed and validated and is performed at the Eluthia Laboratory (panels SCA and MD) in Heidelberg. The MHD panel is performed at the Heidelberg University Hospital Metabolic Screening Centre which also performs the government sponsored newborn screening for Southern Germany.

 
 
PELICAN
Why choose neoBona?

Pelican Feminine Healthcare Ltd is a UK manufacturer of single-use medical instruments for Gynaecology and Obstetrics, including the market leading PELIspec® vaginal speculum.

State-of-the-art manufacturing facilities and active research and development highlight Pelican Feminine Healthcare’s commitment to the continuous development of innovative healthcare solutions in Women’s health.